Literature DB >> 19812158

The canine papillomavirus e5 protein signals from the endoplasmic reticulum.

Rachel Condjella1, Xuefeng Liu, Frank Suprynowicz, Hang Yuan, Sawali Sudarshan, Yuhai Dai, Richard Schlegel.   

Abstract

The recently discovered Canis familiaris papillomavirus (PV) type 2 (CfPV2) provides a unique opportunity to study PV gene functions in vitro and in vivo. Unlike the previously characterized canine oral PV, CfPV2 contains an E5 open reading frame and is associated with progression to squamous cell carcinoma. In the current study, we have expressed and characterized the CfPV2-encoded E5 protein, a small, hydrophobic, 41-amino-acid polypeptide. We demonstrate that, similar to the E5 protein from high-risk human PV type 16, the CfPV2 E5 protein is localized in the endoplasmic reticulum (ER) and that its expression decreases keratinocyte proliferation and cell life span. E5 expression also increases the percentage of cells in the G(1) phase of the cell cycle, with a concomitant decrease in the percentage of cells in S phase. To identify a potential mechanism for E5-mediated growth inhibition from the ER, we developed a real-time PCR method to quantify the splicing of XBP1 mRNA as a measure of ER stress. We found that the CfPV2 E5 protein induced ER stress and that this, as well as the observed growth inhibition, is tempered significantly by coexpression of the CfPV2 E6 and E7 genes. It is possible that the spatial/temporal regulation of E6/E7 gene expression during keratinocyte differentiation might therefore modulate E5 activity and ER stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812158      PMCID: PMC2786831          DOI: 10.1128/JVI.01003-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner.

Authors:  Sven Miller; Stefan Kastner; Jacomine Krijnse-Locker; Sandra Bühler; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

2.  The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.

Authors:  H Stöppler; D P Hartmann; L Sherman; R Schlegel
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

3.  E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain.

Authors:  G Hossein Ashrafi; Mohammad Haghshenas; Barbara Marchetti; M Saveria Campo
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

4.  Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.

Authors:  D Drummond-Barbosa; R R Vaillancourt; A Kazlauskas; D DiMaio
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

5.  Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants.

Authors:  J Sparkowski; J Anders; R Schlegel
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress.

Authors:  Chia-Yi Yu; Yun-Wei Hsu; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response.

Authors:  Baozong Li; Bo Gao; Linbai Ye; Xue Han; Wei Wang; Lingbao Kong; Xiaonan Fang; Yingchun Zeng; Hong Zheng; Shanshan Li; Zhenghui Wu; Li Ye
Journal:  Virus Res       Date:  2006-11-07       Impact factor: 3.303

8.  Cloning and characterization of human karyopherin beta3.

Authors:  N R Yaseen; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

Authors:  J A Suzich; S J Ghim; F J Palmer-Hill; W I White; J K Tamura; J A Bell; J A Newsome; A B Jenson; R Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

10.  Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.

Authors:  A Staebler; J H Pierce; S Brazinski; M A Heidaran; W Li; R Schlegel; D J Goldstein
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more
  7 in total

1.  Complete genome sequence of canine papillomavirus type 9.

Authors:  Hang Yuan; Jennifer Luff; Dan Zhou; Jingang Wang; Verena Affolter; Peter Moore; Richard Schlegel
Journal:  J Virol       Date:  2012-05       Impact factor: 5.103

2.  Complete genome sequence of canine papillomavirus type 10.

Authors:  Jennifer Luff; Peter Moore; Dan Zhou; Jingang Wang; Yukari Usuda; Verena Affolter; Richard Schlegel; Hang Yuan
Journal:  J Virol       Date:  2012-10       Impact factor: 5.103

3.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.

Authors:  Sawali R Sudarshan; Richard Schlegel; Xuefeng Liu
Journal:  Biochem Biophys Res Commun       Date:  2010-08-03       Impact factor: 3.575

Review 4.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

5.  Complete genome sequence of canine papillomavirus type 16.

Authors:  Jennifer Luff; Michelle Mader; Monica Britton; Joseph Fass; Peter Rowland; Carolyn Orr; Richard Schlegel; Hang Yuan
Journal:  Genome Announc       Date:  2015-05-07

6.  Complete genome sequence of canine papillomavirus virus type 12.

Authors:  Dan Zhou; Jennifer Luff; Siddhartha Paul; Faris Alkhilaiwi; Yukari Usuda; Naidong Wang; Verena Affolter; Peter Moore; Richard Schlegel; Hang Yuan
Journal:  Genome Announc       Date:  2015-04-16

7.  Human papillomavirus oncoproteins and apoptosis (Review).

Authors:  Peiyue Jiang; Ying Yue
Journal:  Exp Ther Med       Date:  2013-10-30       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.